Literature DB >> 24435008

Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis.

Mohammad Roshan Soobratty1, Ruth Whitfield, Krithika Subramaniam, Grace Grove, Anthony Carver, Grace V O'Donovan, Houdini H T Wu, Oona Y-C Lee, Ramasamyiyer Swaminathan, Graham F Cope, Heather J Milburn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24435008     DOI： 10.1183/09031936.00132613

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Latent Tuberculosis in Health Care Workers Exposed to Active Tuberculosis in a Tertiary Care Hospital in Oman.

Authors:  Faryal Khamis; Adil Al-Lawati; Ibrahim Al-Zakwani; Seif Al-Abri; Jaleelah Al-Naamani; Harith Al-Harthi; Amina Al-Jardani; Aliya Al-Harthi
Journal:  Oman Med J       Date:  2016-07

2.  The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial.

Authors:  Sara Lodi; Nneka I Emenyonu; Kara Marson; Dalsone Kwarisiima; Robin Fatch; Michael G McDonell; Debbie M Cheng; Harsha Thirumurthy; Monica Gandhi; Carol S Camlin; Winnie R Muyindike; Judith A Hahn; Gabriel Chamie
Journal:  Trials       Date:  2021-05-20       Impact factor: 2.279

3.  Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.

Authors:  Emily A Kendall; Betina Durovni; Neil A Martinson; Solange Cavalacante; Katlego Masonoke; Valeria Saraceni; Limakatso Lebina; Anne Efron; Silvia Cohn; Sandy Chon; Richard E Chaisson; David W Dowdy; Jonathan E Golub
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

4.  PrEP implementation research in Africa: what is new?

Authors:  Frances M Cowan; Sinead Delany-Moretlwe; Eduard J Sanders; Nelly R Mugo; Fernand A Guedou; Michel Alary; Luc Behanzin; Owen Mugurungi; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

5.  Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis.

Authors:  Sylvia M LaCourse; Daniel Leon; Nuttada Panpradist; Barbra A Richardson; Elizabeth Maleche-Obimbo; Jerphason Mecha; Daniel Matemo; Jaclyn N Escudero; John Kinuthia; Barry Lutz; Grace John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2021-01       Impact factor: 2.129

6.  Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial.

Authors:  Sarah Iribarren; Hannah Milligan; Kyle Goodwin; Omar Alfonso Aguilar Vidrio; Cristina Chirico; Hugo Telles; Daniela Morelli; Barry Lutz; Jennifer Sprecher; Fernando Rubinstein
Journal:  JMIR Res Protoc       Date:  2021-06-21

7.  Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.

Authors:  Ramnath Subbaraman; Laura de Mondesert; Angella Musiimenta; Madhukar Pai; Kenneth H Mayer; Beena E Thomas; Jessica Haberer
Journal:  BMJ Glob Health       Date:  2018-10-11

8.  Evaluation of the Accuracy of 99DOTS, a Novel Cellphone-based Strategy for Monitoring Adherence to Tuberculosis Medications: Comparison of DigitalAdherence Data With Urine Isoniazid Testing.

Authors:  Beena E Thomas; J Vignesh Kumar; M Chiranjeevi; Daksha Shah; Amit Khandewale; Kannan Thiruvengadam; Jessica E Haberer; Kenneth H Mayer; Ramnath Subbaraman
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.

Authors:  Olivia F Hunter; Furaha Kyesi; Amrit Kaur Ahluwalia; Zeinabou Niamé Daffé; Patricia Munseri; C Fordham von Reyn; Lisa V Adams
Journal:  BMC Infect Dis       Date:  2020-10-07       Impact factor: 3.090

10.  Understanding Nonadherence to Tuberculosis Medications in India Using Urine Drug Metabolite Testing: A Cohort Study.

Authors:  Ramnath Subbaraman; Beena E Thomas; J Vignesh Kumar; Kannan Thiruvengadam; Amit Khandewale; S Kokila; Maya Lubeck-Schricker; M Ranjith Kumar; Gunjan Rahul Gaurkhede; Apurva Shashikant Walgude; J Hephzibah Mercy; Jagannath Dattatraya Kumbhar; Misha Eliasziw; Kenneth H Mayer; Jessica E Haberer
Journal:  Open Forum Infect Dis       Date:  2021-05-05       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.